4-chloro-7-methoxy-N-methylquinoline-6-carboxamide (CAS No: 417723-63-8) is a key pharmaceutical intermediate used in the synthesis of APIs Lenvatinib and Zanzalintinib. This compound serves as an essential raw material in API development and synthesis. Explore detailed chemical properties, molecular data, structure information, and verified global suppliers, manufacturers, and distributors of this API intermediate on apicule.
Alternate Names: Lenvatinib Impurity 109, 4-Chloro-7-methoxyquinoline-6-carboxylic acid methylamide
CAS No: 417723-63-8
PubChem CID: 58930933
Mol Formula: C12H11ClN2O2
Mol Weight: 250.68 g/mol
Used in APIs: Lenvatinib and Zanzalintinib
IUPAC Name: 4-chloro-7-methoxy-N-methylquinoline-6-carboxamide
API Intermediate Description: 4-chloro-7-methoxy-N-methylquinoline-6-carboxamide (or its related amide form) is a crucial intermediate in the chemical synthesis process to create the anti-cancer drug Lenvatinib, acting as a key building block that undergoes further reactions (like substitution) to form the final active molecule, a tyrosine kinase inhibitor used for thyroid, liver, kidney, and endometrial cancers.
